En Es
Categories

Industry News

CT System Receives FDA Clearance for AI-Based Image Reconstruction Technology

By Medimaging International staff writers
07 Nov 2019

Image: The AiCE technology is intended to enable clinicians to perform super-high resolution studies on the Aquilion Precision CT system (Photo courtesy of Canon Medical Systems).Canon Medical Systems USA, Inc. (Tustin, CA, USA; www.us.medical.canon) has received 510(k) clearance for its Advanced Intelligent Clear-IQ Engine (AiCE) for the Aquilion Precision, further expanding access to its new deep convolutional neural network (DCNN) image reconstruction technology. The technology, which is now available on Canon’s Aquilion Precision and Aquilion ONE/GENESIS Edition CT systems, uses a deep learning algorithm to differentiate signal from noise so that it can suppress noise while enhancing signal, thus improving CT image reconstruction.

Aquilion Precision, the world’s first ultra-high resolution CT, provides two times the resolution of conventional CT, revealing details that are typically only seen in Cath labs. With AiCE, the system now enables clinicians to perform super-high resolution studies at doses equivalent to standard resolution CT (with traditional hybrid iterative reconstruction techniques). AiCE learns from the high image quality of Model Based Iterative Reconstruction (MBIR) to reconstruct CT images with improved high contrast spatial resolution.

“As we strive for precision medicine, we realize the importance of starting with the foundation of a precise diagnosis. Canon Medical is committed to developing intelligent solutions that help providers generate clearer, more holistic images to help achieve better outcomes, without increasing dose,” said Tim Nicholson, acting managing director, CT Business Unit, Canon Medical Systems USA. “This technology represents a new era in image reconstruction, which may help provide more possibilities in improving patient care than ever before.”

Related Links:
Canon Medical Systems Corporation



E-mail Print
FaceBook Twitter Google+ Linked in

CANON

Canon U.S.A., Inc. provides digital imaging solutions for the healthcare sector, including digital detectors, digital radiography / fluoroscopy solutions, mobile & portable solutions, acquisition carts, and software solutions.
More info

More articles about CANON

06 Jul 2019
AI-Based Image Reconstruction Solution Receives FDA Clearance
Canon Medical Systems USA, Inc. has received 510(k) clearance from the FDA for its new deep convolutional neural network (DCNN) image reconstruction technology.
Read More
05 Apr 2018
Canon Medical Systems Initiates Collaborative Research On AI in MR Imaging
Canon Medical Systems Corporation, along with Kumamoto University and the University of Bordeaux, has initiated collaborative research on the application of Deep Learning Reconstruction (DLR), an Artificial Intelligence (AI)-based technology in magnetic resonance (MR) imaging.
Read More
09 Jan 2018
Toshiba Medical Systems Changes Name to Canon Medical Systems
The official corporate name of Toshiba Medical Systems Corporation has been changed to Canon Medical Systems Corporation. The name change follows the completion of procedures for obtaining regulatory approval for integration with the Canon Group after the company officially became a subsidiary of Canon Inc. in December 2016. Similarly, Toshiba America Medical Systems, now a Canon group company, has been officially named as Canon Medical Systems USA, Inc.
Read More
22 Dec 2016
Canon Completes Acquisition of Toshiba Medical
Japanese electronics manufacturer Canon Inc. has completed its acquisition of Toshiba Medical Systems Corp., a medical unit of Toshiba Corp. that provides medical imaging products and solutions. Canon has received the necessary clearance from competition regulatory authorities to make Toshiba Medical its subsidiary in a USD 54.7 billion deal.
Read More

Additional news

27 Jun 2022
Robot-Assisted Surgical Devices Market Driven by Increased Demand for Patient-Specific Surgeries
Given the growing incidence of lifestyle diseases and demand for affordable healthcare, effective surgery using robotic devices can result in a decline in treatment costs and drive the growth of the global robot-assisted surgical devices (RASD) market.
Read More
24 Jun 2022
Fujirebio Acquires ADx NeuroSciences to Speed Development of Neurodegenerative Diseases Diagnostic Tests
Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction of customary closing conditions.
Read More
23 Jun 2022
Hospital Microbiology Testing Market Driven by Increasing Prevalence of Chronic Diseases
Rising medical expenditure as well as the presence of well-established modern healthcare infrastructure in various developed as well as developing regions is fueling the growth of the global hospital microbiology testing market.
Read More
22 Jun 2022
Global Minimally Invasive Surgery (MIS) Market to Surpass USD 325 Billion by 2031
The global MIS market is projected to surpass USD 325 billion by 2031, driven by growing patient awareness of the advantages of MIS over open surgeries, continuous innovation in surgical robots, and constant advancements in other MIS-associated technologies during the 2022-2031 forecast period.
Read More
21 Jun 2022
Medix Biochemica Acquires IVD Raw Materials Producer Bioresource Technology
Medix Biochemica (Espoo, Finland) has acquired 100% of the shares of Bioresource Technology (BRT, Weston, FL, USA) to broaden its base matrix capabilities and further strengthen its local presence in the US market.
Read More
21 Jun 2022
Global Bedside Testing Market to Witness Promising Prospects in Critical Care
Point-of-care or point-of-use diagnostics, also known as bedside testing, has gained increased prominence in analytical testing over the past few years as it provides clinically relevant information without the need for a dedicated laboratory.
Read More
20 Jun 2022
Global Sepsis Diagnostics Market Driven by Rising Hospital-Acquired Illnesses
The global sepsis diagnostics market is expected to grow at a CAGR of 8.3% during the period 2022-2028 to reach almost USD 0.88 billion by 2028, driven by a rise in the number of hospital-acquired illnesses and the rapidly growing molecular diagnostics market, although the high cost of automated diagnostic instruments could hamper market growth.
Read More
14 Jun 2022
BD Partners with Mayo Clinic Platform for Access to World's Largest Collection of Clinical Data
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA) has entered into a collaboration with Mayo Clinic Platform (Rochester, MN, USA) to access de-identified patient data from Mayo Clinic Platform_Discover.
Read More
14 Jun 2022
Quidel Partners with Global Lyme Alliance, Leads in Lyme Disease Testing
Quidel Corporation (San Diego, CA, USA) is joining forces with Global Lyme Alliance (Stamford, CT, USA) to heighten public awareness around Lyme disease during Lyme Disease Awareness Month (in May) and beyond.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions